Condition
Non-small Cell Lung Cancer Stage IV clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Non-small Cell Lung Cancer Stage IV clinical trials that are recruiting, at sites in 2 countries (most in United States (4), Sweden (1)). By phase: Phase 2 (3), Phase 1/2 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Non-small Cell Lung Cancer Stage IV clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| First-Line Ipilimumab, Nivolumab, and IL-15 Superagonist in Advanced or Recurrent NSCLC | Phase 1/2 | St Louis, Missouri | Recruiting | Jan 21, 2026 |
| Proteomic-guided, risk-adapted therapy for advanced non-small cell lung cancer | Phase 2 | Chico, California and 3 other locations | Recruiting | Nov 26, 2025 |
| Pulmonary rehabilitation for people who survived advanced non-small cell lung cancer | Phase 2 | Cleveland, Ohio | Recruiting | Aug 5, 2025 |
| First human use of 177Lu‑AKIR001 for CD44v6‑positive advanced cancers | Early Phase 1 | Stockholm, Stockholm County | Recruiting | Oct 15, 2024 |
| New treatment for advanced non-small-cell lung cancer using a virus and chemotherapy | Phase 2 | Bullhead City, Arizona and 14 other locations | Recruiting | Jun 18, 2024 |
All recruiting trials (5)
-
First-Line Ipilimumab, Nivolumab, and IL-15 Superagonist in Advanced or Recurrent NSCLC
A phase Ib/II study tests whether adding nogapendekin alfa inbakicept to nivolumab and ipilimumab helps people with stage IV or recurrent non-small cell lung cancer.
-
Proteomic-guided, risk-adapted therapy for advanced non-small cell lung cancer
This trial tests whether using a proteomic test plus a toxicity risk tool to pick immune checkpoint inhibitor–based treatment can improve 12-month progression-free survival for people with previously untreated advanced non-small cell lung cancer.
-
Pulmonary rehabilitation for people who survived advanced non-small cell lung cancer
This research will try an eight-week pulmonary rehabilitation program to see if it helps people with advanced non-small cell lung cancer breathe easier and have more energy.
-
First human use of 177Lu‑AKIR001 for CD44v6‑positive advanced cancers
This trial tests a Lutetium‑177 radiolabeled drug (AKIR001) in adults with advanced, irresectable CD44v6‑expressing solid tumors who have no reasonable systemic treatment options.
-
New treatment for advanced non-small-cell lung cancer using a virus and chemotherapy
This study is testing a new treatment that combines a special virus and chemotherapy to see if it can help people with advanced lung cancer who haven't responded to previous treatments.
Related topics
Quick answers
How many Non-small Cell Lung Cancer Stage IV clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (4 trials), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.